Low-dose aspirin and survival from lung cancer: a population-based cohort study


Preclinical evidence suggests that aspirin may inhibit lung cancer progression. In a large cohort of lung cancer patients, we investigated whether low-dose aspirin use was associated with a reduction in the risk of lung cancer-specific mortality. We identified lung cancer patients from English cancer registries diagnosed between 1998 to 2009 from the… (More)
DOI: 10.1186/s12885-015-1910-9


6 Figures and Tables


Citations per Year

Citation Velocity: 14

Averaging 14 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.